Eva Wolf: You are right
Triple agonists such as retatrutide target GLP-1, GIP, and glucagon receptors and are still investigational
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse
Keep a basic sleep diary noting bedtime, estimated time to fall asleep, number of awakenings, wake time, and subjective sleep quality (scale of 1 to 10)
price/availability frequently compared